Linda Halldner

3.9k total citations · 1 hit paper
34 papers, 2.7k citations indexed

About

Linda Halldner is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Physiology. According to data from OpenAlex, Linda Halldner has authored 34 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 13 papers in Cognitive Neuroscience and 11 papers in Physiology. Recurrent topics in Linda Halldner's work include Attention Deficit Hyperactivity Disorder (14 papers), Adenosine and Purinergic Signaling (11 papers) and Autism Spectrum Disorder Research (9 papers). Linda Halldner is often cited by papers focused on Attention Deficit Hyperactivity Disorder (14 papers), Adenosine and Purinergic Signaling (11 papers) and Autism Spectrum Disorder Research (9 papers). Linda Halldner collaborates with scholars based in Sweden, United States and United Kingdom. Linda Halldner's co-authors include Bertil B. Fredholm, Niklas Långström, Paul Lichtenstein, Henrik Larsson, Giulia Arslan, Gunnar Schulte, Björn Kull, Wyeth W. Wasserman, Johan Zetterqvist and Björn Johansson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Linda Halldner

32 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medication for Attention Deficit–Hyperactivity Disorder and Criminality

2012 391 citations Paul Lichtenstein, Linda Halldner et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linda Halldner Sweden	20	1.1k	882	647	571	542	34	2.7k
Dietrich van Calker Germany	37	1.9k 1.7×	780 0.9×	457 0.7×	1.7k 3.0×	1.6k 2.9×	90	4.9k
David Elmenhorst Germany	24	271 0.3×	230 0.3×	831 1.3×	501 0.9×	253 0.5×	64	1.9k
Gábor Faludi Hungary	28	118 0.1×	614 0.7×	273 0.4×	829 1.5×	762 1.4×	87	2.7k
Paulo Belmonte‐de‐Abreu Brazil	32	112 0.1×	1.7k 2.0×	767 1.2×	655 1.1×	669 1.2×	120	3.6k
Margaret I. Davis United States	26	183 0.2×	116 0.1×	630 1.0×	1.3k 2.3×	638 1.2×	67	3.1k
Maurício Kunz Brazil	23	107 0.1×	1.5k 1.7×	311 0.5×	364 0.6×	266 0.5×	56	2.7k
Keila Maria Mendes Ceresér Brazil	24	110 0.1×	1.2k 1.4×	277 0.4×	416 0.7×	250 0.5×	59	2.4k
Angelika Erhardt Germany	26	73 0.1×	225 0.3×	444 0.7×	384 0.7×	555 1.0×	70	2.3k
Joseph K. Belanoff United States	29	135 0.1×	272 0.3×	114 0.2×	296 0.5×	303 0.6×	47	2.8k
Peter Andiné Sweden	22	114 0.1×	225 0.3×	173 0.3×	877 1.5×	535 1.0×	55	2.0k

Countries citing papers authored by Linda Halldner

Since Specialization

Citations

This map shows the geographic impact of Linda Halldner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Halldner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Halldner more than expected).

Fields of papers citing papers by Linda Halldner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Halldner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Halldner. The network helps show where Linda Halldner may publish in the future.

Co-authorship network of co-authors of Linda Halldner

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Halldner. A scholar is included among the top collaborators of Linda Halldner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Halldner. Linda Halldner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wintzell, Viktor, Philip Brenner, Linda Halldner, et al.. (2025). Montelukast Use and the Risk of Neuropsychiatric Adverse Events in Children. JAMA Pediatrics. 179(4). 418–418. 3 indexed citations

Kindblom, Jenny M., et al.. (2025). Children and Young Adults Who Used Medication for Attention Deficit Hyperactivity Disorder Faced Increased Cardiac Risks. Acta Paediatrica. 114(11). 3021–3033.

Halldner, Linda, et al.. (2023). Symptom similarities and differences in social interaction between autistic children and adolescents with and without ADHD. Current Psychology. 43(4). 3503–3513. 2 indexed citations

Halldner, Linda, Henrik Larsson, Christopher Gillberg, et al.. (2022). Childhood-onset versus adolescent-onset anxiety and depression: Epidemiological and neurodevelopmental aspects. Psychiatry Research. 312. 114556–114556. 9 indexed citations

Larsson, Henrik, et al.. (2022). Internalizing symptoms in adolescence are modestly affected by symptoms of anxiety, depression, and neurodevelopmental disorders in childhood. BMC Psychiatry. 22(1). 233–233. 6 indexed citations

Johnels, Jakob Åsberg, Eva Billstedt, Christopher Gillberg, et al.. (2021). The relationship between intelligence and global adaptive functioning in young people with or without neurodevelopmental disorders. Psychiatry Research. 303. 114076–114076. 10 indexed citations

Johansson, Viktoria, Sven Sandin, Zheng Chang, et al.. (2020). Medications for attention-deficit/hyperactivity disorder in individuals with or without coexisting autism spectrum disorder: analysis of data from the Swedish prescribed drug register. Journal of Neurodevelopmental Disorders. 12(1). 44–44. 5 indexed citations

Durbeej, Natalie, Karolina Sörman, Sebastian Lundström, et al.. (2019). Trends in childhood and adolescent internalizing symptoms: results from Swedish population based twin cohorts. BMC Psychology. 7(1). 50–50. 51 indexed citations

Pettersson, Erik, Paul Lichtenstein, Henrik Anckarsäter, et al.. (2015). Childhood neurodevelopmental problems and adolescent bully victimization: population-based, prospective twin study in Sweden. European Child & Adolescent Psychiatry. 24(9). 1049–1059. 13 indexed citations

10.

Molero, Yasmina, Clara Hellner Gumpert, Eva Serlachius, et al.. (2013). A study of the possible association between adenosine A_2A receptor gene polymorphisms and attention‐deficit hyperactivity disorder traits. Genes Brain & Behavior. 12(3). 305–310. 31 indexed citations

11.

Zetterqvist, Johan, Philip Asherson, Linda Halldner, Niklas Långström, & Henrik Larsson. (2012). Stimulant and non‐stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009. Acta Psychiatrica Scandinavica. 128(1). 70–77. 129 indexed citations

12.

Lichtenstein, Paul, Linda Halldner, Johan Zetterqvist, et al.. (2012). Medication for Attention Deficit–Hyperactivity Disorder and Criminality. New England Journal of Medicine. 367(21). 2006–2014. 391 indexed citations breakdown →

13.

Anckarsäter, Henrik, Sebastian Lundström, Linnéa Kollberg, et al.. (2011). The Child and Adolescent Twin Study in Sweden (CATSS). Twin Research and Human Genetics. 14(6). 495–508. 227 indexed citations

14.

Giménez‐Llort, Lydia, Susan A. Masino, Lihong Diao, et al.. (2005). Mice lacking the adenosine A₁ receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly. Synapse. 57(1). 8–16. 52 indexed citations

15.

Wu, Weiping, Jing‐Xia Hao, Linda Halldner, et al.. (2004). Increased nociceptive response in mice lacking the adenosine A1 receptor. Pain. 113(3). 395–404. 105 indexed citations

16.

Lopes, Luı́sa V., Linda Halldner, Nelson Rebola, et al.. (2004). Binding of the prototypical adenosine A_2A receptor agonist CGS 21680 to the cerebral cortex of adenosine A₁ and A_2A receptor knockout mice. British Journal of Pharmacology. 141(6). 1006–1014. 88 indexed citations

17.

Stenberg, Dag, Erik Litonius, Linda Halldner, et al.. (2003). Sleep and its homeostatic regulation in mice lacking the adenosine A₁receptor. Journal of Sleep Research. 12(4). 283–290. 117 indexed citations

18.

Hao, Jianjun, Linda Halldner, Xiaobo Xu, et al.. (2002). Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptors. Neuroscience. 114(3). 523–527. 41 indexed citations

19.

Halldner, Linda, Gianluca Lozza, Karin Lindström, & Bertil B. Fredholm. (2000). Lack of tolerance to motor stimulant effects of a selective adenosine A2A receptor antagonist. European Journal of Pharmacology. 406(3). 345–354. 46 indexed citations

20.

Fredholm, Bertil B., Giulia Arslan, Linda Halldner, et al.. (2000). Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg s Archives of Pharmacology. 362(4-5). 364–374. 484 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact